QHM-2025-8767 Mansion House Surgery- Local Enhanced Services

The procurement process is conducted by the NHS North East and North Cumbria Integrated Care Board for the provision of Local Enhanced Services at Mansion House Surgery. Specifically, this includes Near Patient Testing, Drug Monitoring, Warfarin Monitoring, Hormonal Injection Administration, and Minor Injuries under the industry category of health services. The project is located in the North East of England, categorised under the CPV code 85100000.

The contract was awarded via a direct award process, commencing on 1 April 2025 and concluding on 31 March 2026. The procurement method utilised is a limited procedure without a prior call for competition as per the Health Care Services (Provider Selection Regime) regulations 2023, specifying that alternate procurement regulations do not apply. The decision was made on 1 October 2025, with the Mansion House Surgery acting as the supplier and the contract marked as active.

This tender offers significant business growth opportunities, especially for entities involved in the healthcare sector providing specialised medical services. Businesses specialised in high-risk drug monitoring, hormonal injection services, or general practice surgeries in the UK region would be well-suited to engage with similar opportunities. The procurement typology and the need for highly specific healthcare services indicate that businesses with established expertise and a capability to swiftly engage in service provision, especially those already operating within the NHS framework, can find this a beneficial opportunity to solidify their positions and expand their service portfolios in the healthcare domain.